Previous 10 | Next 10 |
Novan (NASDAQ: NOVN ) has dosed first patient in its “B-SIMPLE” (Berdazimer Sodium In Molluscum Patients with Lesions) Phase 3 program, designed to evaluate topical nitric oxide product candidate SB206 for the treatment of molluscum contagiosum. More news on: Novan, Inc., H...
Phase 3 pivotal program commences and underway Investigative sites now activated and enrollment activities actioned Anticipated patient demand managed with a highly disciplined approach to trial execution Top line results targeted to be no later than early in the first quarter o...
MORRISVILLE, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN) today announced that it will hold its 2019 Annual Meeting of Stockholders on Wednesday, July 31, at 9:30 am Eastern Time, at the Company’s corporate headquarters located at 4105 ...
Obalon Therapeutics (NASDAQ: OBLN ) -47% on stock offering. More news on: Obalon Therapeutics, Inc., Ascent Capital Group, Inc., Weibo Corporation, Stocks on the move, Read more ...
Gainers: Novan (NASDAQ: NOVN ) +27% . Sea Limited (NYSE: SE ) +23% . Allied Healthcare Products (NASDAQ: AHPI ) +17% . Westwater Resources (NASDAQ: WWR ) +12% . Novus Therapeutics (NASDAQ: NVUS ) +12% . Spherix Incorporated (NASDAQ: SPEX ) +11% . CSW Industrials (NASDAQ: CSWI )...
Gainers: Can-Fite BioPharma (NYSEMKT: CANF ) +38% . Outlook Therapeutics (NASDAQ: OTLK ) +30% . Del Frisco's Restaurant Group (NASDAQ: DFRG ) +27% . Orion Energy Systems (NASDAQ: OESX ) +23% . Sprint Corporation (NYSE: S ) +22% . ENDRA Life Sciences (NASDAQ: NDRA ) +18% . Sesen...
Gainers: Outlook Therapeutics (NASDAQ: OTLK ) +56% . Golden Bull (NASDAQ: DNJR ) +22% . Dunxin Financial Holdings (NYSEMKT: DXF ) +21% . Cray (NASDAQ: CRAY ) +19% . 21Vianet Group (NASDAQ: VNET ) +15% . Soliton (NASDAQ: SOLY ) +14% . Citius Pharmaceuticals (NASDAQ: CTXR ) +13%...
Gainers: Amber Road (NYSE: AMBR ) +26% . Marathon Patent Group (NASDAQ: MARA ) +25% . Riot Blockchain (NASDAQ: RIOT ) +18% . P.A.M. Transportation Services (NASDAQ: PTSI ) +18% . Ocean Power Technologies (NASDAQ: OPTT ) +17% . Charles & Colvard (NASDAQ: CTHR ) +15% . ATA (N...
MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the treatment of atopic dermatitis and Phase 2 trial with SB206 gel for the treatment of mo...
Ligand Pharmaceuticals ( LGND +1.1% ) has acquired the economic rights to Novan's ( NOVN -0.5% ) SB206, a topical antiviral gel in Phase 3 development for skin infections, for $12M in upfront cash, up to $20M in milestones and tiered royalties of 7 - 10%. More news on: Ligand Pharmac...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...